{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:51:53Z","timestamp":1794635513567,"version":"4.9.1"},"reference-count":215,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    The type 5 metabotropic glutamate receptor, mGlu\n                    <jats:sub>5<\/jats:sub>\n                    , has been proposed as a potential therapeutic target for the treatment of several neurodegenerative diseases. In preclinical neurodegenerative disease models, novel allosteric modulators have been shown to improve cognitive performance and reduce disease-related pathology. A common pathological hallmark of neurodegenerative diseases is a chronic neuroinflammatory response, involving glial cells such as astrocytes and microglia. Since mGlu\n                    <jats:sub>5<\/jats:sub>\n                    is expressed in astrocytes, targeting this receptor could provide a potential mechanism by which neuroinflammatory processes in neurodegenerative disease may be modulated. This review will discuss current evidence that highlights the potential of mGlu\n                    <jats:sub>5<\/jats:sub>\n                    allosteric modulators to treat neurodegenerative diseases, including Alzheimer\u2019s disease, Huntington\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis. Furthermore, this review will explore the role of mGlu\n                    <jats:sub>5<\/jats:sub>\n                    in neuroinflammatory responses, and the potential for this G protein-coupled receptor to modulate neuroinflammation.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2022.893422","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T01:47:00Z","timestamp":1652233620000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?"],"prefix":"10.3389","volume":"13","author":[{"given":"Rebecca F.","family":"Budgett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geor","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Sergeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstie A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie J.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abd2494","article-title":"A\u03b2 Oligomers Induce Pathophysiological mGluR5 Signaling in Alzheimer's Disease Model Mice in a Sex-Selective Manner","volume":"13","author":"Abd-Elrahman","year":"","journal-title":"Sci. Signal"},{"key":"B2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13041-019-0456-1","article-title":"Modulation of mTOR and CREB Pathways Following mGluR5 Blockade Contribute to Improved Huntington's Pathology in zQ175 Mice","volume":"12","author":"Abd-Elrahman","year":"2019","journal-title":"Mol. Brain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aan6387","article-title":"mGluR5 Antagonism Increases Autophagy and Prevents Disease Progression in the zQ175 Mouse Model of Huntington's Disease","volume":"10","author":"Abd-Elrahman","year":"2017","journal-title":"Sci. Signal"},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13041-018-0364-9","article-title":"Autophagy Is Increased Following Either Pharmacological or Genetic Silencing of mGluR5 Signaling in Alzheimer's Disease Mouse Models","volume":"11","author":"Abd-Elrahman","year":"2018","journal-title":"Mol. Brain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1111\/BPH.15750","article-title":"A Positive Allosteric Modulator for the Muscarinic Receptor (M1 mAChR) Improves Pathology and Cognitive Deficits in Female APPswe\/PSEN1\u0394E9 Mice","volume":"179","author":"Abd-Elrahman","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1101\/803262","article-title":"A\u03b2 Oligomers Induce Sex-Selective Differences in mGluR5 Pharmacology and Pathophysiological Signaling in Alzheimer Mice","author":"Abd-Elrahman","year":"2019","journal-title":"bioRxiv"},{"key":"B7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/ANNUREV-PHARMTOX-021821-091747","article-title":"Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease","volume":"62","author":"Abd-Elrahman","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1021\/acsptsci.0c00013","article-title":"mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-dependent","volume":"3","author":"Abd-Elrahman","year":"","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"652750","DOI":"10.1155\/2014\/652750","article-title":"Metabotropic Glutamate Receptor 5 Negative Modulation in Phase I Clinical Trial: Potential Impact of Circadian Rhythm on the Neuropsychiatric Adverse Reactions-Do Hallucinations Matter?","volume":"2014","author":"Abou Farha","year":"2014","journal-title":"ISRN Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1046\/j.1471-4159.2000.0741666.x","article-title":"Elevated Cortical Extracellular Fluid Glutamate in Transgenic Mice Expressing Human Mutant (G93A) Cu\/Zn Superoxide Dismutase","volume":"74","author":"Alexander","year":"2000","journal-title":"J. Neurochem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"34840","DOI":"10.1074\/jbc.M504508200","article-title":"Inhibition of Metabotropic Glutamate Receptor Signaling by the Huntingtin-Binding Protein Optineurin","volume":"280","author":"Anborgh","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00001756-200402090-00012","article-title":"Differential Expression of mGluR5 in Human Lumbosacral Motoneurons","volume":"15","author":"Anneser","year":"2004","journal-title":"Neuroreport"},{"key":"B13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0306-4522(01)00181-6","article-title":"Immunohistochemical Localization of Group I and II Metabotropic Glutamate Receptors in Control and Amyotrophic Lateral Sclerosis Human Spinal Cord: Upregulation in Reactive Astrocytes","volume":"105","author":"Aronica","year":"2001","journal-title":"Neuroscience"},{"key":"B14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/MOL.119.119032\/-\/DC1","article-title":"Detailed In Vitro Pharmacological Characterization of Clinically Tested Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5","volume":"98","author":"Arsova","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/FNCEL.2018.00488\/BIBTEX","article-title":"Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/J.1471-4159.2001.00075.X","article-title":"Activation of Microglia by Secreted Amyloid Precursor Protein Evokes Release of Glutamate by Cystine Exchange and Attenuates Synaptic Function","volume":"76","author":"Barger","year":"2001","journal-title":"J. Neurochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1523\/JNEUROSCI.3831-03.2004","article-title":"Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Contributes to the Development of Nigro-Striatal Damage Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice","volume":"24","author":"Battaglia","year":"2004","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"107785","DOI":"10.1016\/j.neuropharm.2019.107785","article-title":"A Positive Allosteric Modulator of mGluR5 Promotes Neuroprotective Effects in Mouse Models of Alzheimer's Disease","volume":"160","author":"Bellozi","year":"2019","journal-title":"Neuropharmacology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/BS.APHA.2020.03.001","article-title":"Structure-based Discovery and Development of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators","volume":"88","author":"Bennett","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/MDS.23616","article-title":"AFQ056 Treatment of Levodopa-Induced Dyskinesias: Results of 2 Randomized Controlled Trials","volume":"26","author":"Berg","year":"2011","journal-title":"Mov. Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/JMG.2008.063701","article-title":"A Pilot Open Label, Single Dose Trial of Fenobam in Adults with Fragile X Syndrome","volume":"46","author":"Berry-Kravis","year":"2009","journal-title":"J. Med. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.2967\/JNUMED.118.210658","article-title":"Longitudinal Characterization of mGluR5 Using 11C-Abp688 PET Imaging in the Q175 Mouse Model of Huntington Disease","volume":"59","author":"Bertoglio","year":"2018","journal-title":"J. Nucl. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/MDS.25920","article-title":"The mGluR5 Negative Allosteric Modulator Dipraglurant Reduces Dyskinesia in the MPTP Macaque Model","volume":"29","author":"Bezard","year":"2014","journal-title":"Mov. Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1046\/J.1471-4159.1999.721671.X","article-title":"Expression and Signaling of Group I Metabotropic Glutamate Receptors in Astrocytes and Microglia","volume":"72","author":"Biber","year":"1999","journal-title":"undefined"},{"key":"B25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/J.NEULET.2010.09.043","article-title":"Protective Effect of Metabotropic Glutamate mGluR5 Receptor Elimination in a 6-hydroxydopamine Model of Parkinson's Disease","volume":"486","author":"Black","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/J.NEUROPHARM.2017.06.020","article-title":"In-vivo Effects of Knocking-Down Metabotropic Glutamate Receptor 5 in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis","volume":"123","author":"Bonifacino","year":"2017","journal-title":"Neuropharmacology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2019.05.007","article-title":"In-vivo Genetic Ablation of Metabotropic Glutamate Receptor Type 5 Slows Down Disease Progression in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis","volume":"129","author":"Bonifacino","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1124\/MOL.110.068882","article-title":"Quantitative Analysis Reveals Multiple Mechanisms of Allosteric Modulation of the mGlu5 Receptor in Rat Astroglia","volume":"79","author":"Bradley","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5669","DOI":"10.1523\/jneurosci.22-13-05669.200220026513","article-title":"Chronic but Not Acute Treatment with a Metabotropic Glutamate 5 Receptor Antagonist Reverses the Akinetic Deficits in a Rat Model of Parkinsonism","volume":"22","author":"Breysse","year":"2002","journal-title":"J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12974-015-0439-9","article-title":"PET Imaging Studies Show Enhanced Expression of mGluR5 and Inflammatory Response during Progressive Degeneration in ALS Mouse Model Expressing SOD1-G93a Gene","volume":"12","author":"Brownell","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/GLIA.20783","article-title":"Metabotropic Glutamate Receptor 5 Activation Inhibits Microglial Associated Inflammation and Neurotoxicity","volume":"57","author":"Byrnes","year":"2009","journal-title":"Glia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/(sici)1098-1136(20000101)29:1<70::aid-glia7>3.0.co;2-v","article-title":"Metabotropic Glutamate Receptors in Acutely Isolated Hippocampal Astrocytes: Developmental Changes of mGluR5 mRNA and Functional Expression","volume":"29","author":"Cai","year":"2000","journal-title":"Glia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/J.NEUINT.2019.03.020","article-title":"Metabotropic Glutamate Receptor 5 Ablation Accelerates Age-Related Neurodegeneration and Neuroinflammation","volume":"126","author":"Carvalho","year":"2019","journal-title":"Neurochem. Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/J.BRAINRES.2008.12.082","article-title":"Up-regulation of Astrocyte Metabotropic Glutamate Receptor 5 by Amyloid-\u03b2 Peptide","volume":"1260","author":"Casley","year":"2009","journal-title":"Brain Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000369813","article-title":"Epidemiology of Amyotrophic Lateral Sclerosis and Effect of Riluzole on Disease Course","volume":"44","author":"Cetin","year":"2015","journal-title":"Neuroepidemiology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-014-0190-7\/FIGURES\/8","article-title":"Inhibition of Metabotropic Glutamate Receptor 5 Induces Cellular Stress through Pertussis Toxin-Sensitive Gi-Proteins in Murine BV-2 Microglia Cells","volume":"11","author":"Chantong","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1021\/ACS.JMEDCHEM.5B00892","article-title":"Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-Fluoropyridin-2-Yl)pyrimidin-4-Yl]benzonitrile)","volume":"58","author":"Christopher","year":"2015","journal-title":"J. Med. Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1021\/ACSMEDCHEMLETT.5B00181","article-title":"Discovery of VU0409551\/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia","volume":"6","author":"Conde-Ceide","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and Functions of Metabotropic Glutamate Receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0960-894X(02)00997-6","article-title":"[3H]-methoxymethyl-MTEP and [3H]-Methoxy-PEPy: Potent and Selective Radioligands for the Metabotropic Glutamate Subtype 5 (mGlu5) Receptor","volume":"13","author":"Cosford","year":"2003","journal-title":"Bioorg Med. Chem. Lett."},{"key":"B42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/S13041-020-00657-7","article-title":"mGluR5 Regulates REST\/NRSF Signaling through N-Cadherin\/\u03b2-Catenin Complex in Huntington's Disease","volume":"13","author":"De Souza","year":"2020","journal-title":"Mol. Brain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jamaneurol.2015.2397","article-title":"Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson Disease","volume":"72","author":"DeLong","year":"2015","journal-title":"JAMA Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: an Analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","article-title":"The Neuropathological Diagnosis of Alzheimer's Disease","volume":"14","author":"Deture","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"B46","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.pharmthera.2005.01.008","article-title":"Regulation of Metabotropic Glutamate Receptor Signaling, Desensitization and Endocytosis","volume":"111","author":"Dhami","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nbd.2014.08.021","article-title":"The mGluR5 Positive Allosteric Modulator, CDPPB, Ameliorates Pathology and Phenotypic Signs of a Mouse Model of Huntington's Disease","volume":"73","author":"Doria","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jnc.14555","article-title":"The mGluR5 Positive Allosteric Modulator VU0409551 Improves Synaptic Plasticity and Memory of a Mouse Model of Huntington's Disease","volume":"147","author":"Doria","year":"2018","journal-title":"J. Neurochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/bph.12164","article-title":"Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators Are Neuroprotective in a Mouse Model of Huntington's Disease","volume":"169","author":"Doria","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/GLIA.21086","article-title":"Neuroinflammation Is Associated with Changes in Glial mGluR5 Expression and the Development of Neonatal Excitotoxic Lesions","volume":"59","author":"Drouin-Ouellet","year":"2011","journal-title":"Glia"},{"key":"B51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3233\/JHD-160200","article-title":"Targeting the Cholinergic System to Develop a Novel Therapy for Huntington's Disease","volume":"5","author":"D\u2019Souza","year":"2016","journal-title":"Jhd"},{"key":"B52","doi-asserted-by":"publisher","first-page":"13571","DOI":"10.1038\/ncomms13571","article-title":"Transduction of Group I mGluR-Mediated Synaptic Plasticity by \u03b2-arrestin2 Signalling","volume":"7","author":"Eng","year":"2016","journal-title":"Nat. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/S41593-020-00783-4","article-title":"Reactive Astrocyte Nomenclature, Definitions, and Future Directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/J.TRCI.2019.04.005","article-title":"Alzheimer's Disease Progression and Risk Factors: A Standardized Comparison between Six Large Data Sets","volume":"5","author":"Evans","year":"2019","journal-title":"Alzheimer\u2019s dementia (New York, N. Y.)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1007\/S12035-019-01818-Z\/FIGURES\/8","article-title":"mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson's Disease","volume":"57","author":"Farmer","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/S11064-009-9999-3\/FIGURES\/2","article-title":"Evidence Group I mGluR Drugs Modulate the Activation Profile of Lipopolysaccharide-Exposed Microglia in Culture","volume":"34","author":"Farso","year":"2009","journal-title":"Neurochem. Res."},{"key":"B215","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1021\/ACS.JMEDCHEM.7B00410","article-title":"Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation","volume":"60","author":"Felts","year":"2017","journal-title":"J. Med. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4648","article-title":"\u03b1-Synuclein Interacts with PrPC to Induce Cognitive Impairment through mGluR5 and NMDAR2B","volume":"20","author":"Ferreira","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B58","first-page":"144","article-title":"Phase II Double-Blind Controlled Study of a New Anxiolytic, Fenobam (McN-3377) vs Placebo","volume":"27","author":"Friedmann","year":"1980","journal-title":"Curr. Ther. Res. - Clin. Exp."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/S41401-020-00541-z","article-title":"Subtype-selective Mechanisms of Negative Allosteric Modulators Binding to Group I Metabotropic Glutamate Receptors","volume":"42","author":"Fu","year":"20202020","journal-title":"Acta Pharmacol. Sin."},{"key":"B60","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.1523\/JNEUROSCI.4267-13.2014","article-title":"Astrocyte-Derived BDNF Supports Myelin Protein Synthesis after Cuprizone-Induced Demyelination","volume":"34","author":"Fulmer","year":"2014","journal-title":"J. Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1517\/13543784.2015.1074175","article-title":"Basimglurant for Treatment of Major Depressive Disorder: a Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor 5","volume":"24","author":"Fuxe","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a Potent, Selective and Systemically Active mGlu5 Receptor Antagonist","volume":"38","author":"Gasparini","year":"1999","journal-title":"Neuropharmacology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"102199","DOI":"10.1016\/J.NICL.2020.102199","article-title":"Modelling Prognostic Trajectories of Cognitive Decline Due to Alzheimer's Disease","volume":"26","author":"Giorgio","year":"2020","journal-title":"Neuroimage Clin."},{"key":"B64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/J.NEUROPHARM.2012.05.018","article-title":"Group I Metabotropic Glutamate Autoreceptors Induce Abnormal Glutamate Exocytosis in a Mouse Model of Amyotrophic Lateral Sclerosis","volume":"66","author":"Giribaldi","year":"2013","journal-title":"Neuropharmacology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.NEUROPHARM.2010.07.007","article-title":"Allosteric Modulation of Metabotropic Glutamate Receptors: Structural Insights and Therapeutic Potential","volume":"60","author":"Gregory","year":"2011","journal-title":"Neuropharmacology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/JB\/MVAB140","article-title":"Upregulated mGluR5 Induces ER Stress and DNA Damage by Regulating the NMDA Receptor Subunit NR2B","volume":"171","author":"Gu","year":"2021","journal-title":"J. Biochem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1007\/S00429-014-0812-Y\/FIGURES\/4","article-title":"Decrease of mGluR5 Receptor Density Goes Parallel with Changes in Enkephalin and Substance P Immunoreactivity in Huntington\u2019s Disease: a Preliminary Investigation in the Postmortem Human Brain","volume":"220","author":"Guly\u00e1s","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"B68","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.celrep.2017.06.023.Silent","article-title":"Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes","volume":"20","author":"Haas","year":"2017","journal-title":"Cell Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1177\/0271678X17724681","article-title":"New Astroglial Injury-Defined Biomarkers for Neurotrauma Assessment","volume":"37","author":"Halford","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1756-6606-7-40","article-title":"Metabotropic Glutamate Receptor 5 Knockout Reduces Cognitive Impairment and Pathogenesis in a Mouse Model of Alzheimer's Disease","volume":"7","author":"Hamilton","year":"2014","journal-title":"Mol. Brain"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","article-title":"Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model","volume":"15","author":"Hamilton","year":"2016","journal-title":"Cell Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/NN1997","article-title":"Microglia: Active Sensor and Versatile Effector Cells in the Normal and Pathologic Brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/SREP13869","article-title":"Selective Negative Allosteric Modulation of Metabotropic Glutamate Receptors - A Structural Perspective of Ligands and Mutants","volume":"5","author":"Harps\u00f8e","year":"2015","journal-title":"Sci. Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"R326","DOI":"10.1016\/J.CUB.2021.01.056","article-title":"Astrocytes","volume":"31","author":"Hasel","year":"2021","journal-title":"Curr. Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/FNAGI.2019.00233\/BIBTEX","article-title":"Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities","volume":"11","author":"Hemonnot","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature18942","article-title":"Rapid Signalling in Distinct Dopaminergic Axons during Locomotion and Reward","volume":"535","author":"Howe","year":"20162016","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pbb.2012.03.022","article-title":"Blockade of Metabotropic Glutamate Receptors Inhibits Cognition and Neurodegeneration in an MPTP-Induced Parkinson's Disease Rat Model","volume":"102","author":"Hsieh","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1016\/J.BMCL.2016.07.065","article-title":"Oxazolidinone-based Allosteric Modulators of mGluR5: Defining Molecular Switches to Create a Pharmacological Tool Box","volume":"26","author":"Huang","year":"2016","journal-title":"Bioorg Med. Chem. Lett."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1759091418811021","DOI":"10.1177\/1759091418811021","article-title":"L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats","volume":"10","author":"Huang","year":"2018","journal-title":"ASN Neuro"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1523\/JNEUROSCI.21-06-01838.2001","article-title":"Differential Subcellular Localization of mGluR1a and mGluR5 in the Rat and Monkey Substantia Nigra","volume":"21","author":"Hubert","year":"2001","journal-title":"J. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/BRAIN\/AWX115","article-title":"Transdiagnostic Neurology: Neuropsychiatric Symptoms in Neurodegenerative Diseases","volume":"140","author":"Husain","year":"2017","journal-title":"Brain"},{"key":"B82","doi-asserted-by":"publisher","first-page":"114427","DOI":"10.1016\/J.BCP.2021.114427","article-title":"Optineurin Deletion Disrupts Metabotropic Glutamate Receptor 5-mediated Regulation of ERK1\/2, GSK3\u03b2\/ZBTB16, mTOR\/ULK1 Signaling in Autophagy","volume":"185","author":"Ibrahim","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"64ra1","DOI":"10.1126\/SCITRANSLMED.3001708","article-title":"Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056","volume":"3","author":"Jacquemont","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1570159X14666160321123221","article-title":"Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder","volume":"15","author":"Jaso","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S1740925X09000052","article-title":"Glutamate Elicits Release of BDNF from Basal Forebrain Astrocytes in a Process Dependent on Metabotropic Receptors and the PLC Pathway","volume":"4","author":"Jean","year":"2008","journal-title":"Neuron Glia Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1124\/jpet.110.166629","article-title":"Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-Thiazol-4-Yl)ethynyl]pyridine in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease","volume":"333","author":"Johnston","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"30469","DOI":"10.1074\/JBC.M501775200","article-title":"Functional Metabotropic Glutamate Receptors on Nuclei from Brain and Primary Cultured Striatal Neurons. Role of Transporters in Delivering Ligand","volume":"280","author":"Jong","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"35827","DOI":"10.1074\/JBC.M109.046276","article-title":"Intracellular Metabotropic Glutamate Receptor 5 (mGluR5) Activates Signaling Cascades Distinct from Cell Surface Counterparts","volume":"284","author":"Jong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B89","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/JON.12563","article-title":"18F-FPEB PET\/CT Shows mGluR5 Upregulation in Parkinson's Disease","volume":"29","author":"Kang","year":"2019","journal-title":"J. Neuroimaging"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1097\/WNR.0B013E3280102EE6","article-title":"Mechanisms of Glutamate Receptor Induced Proliferation of Astrocytes","volume":"17","author":"Kanumilli","year":"2006","journal-title":"NeuroReport"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1586\/ERN.11.155","article-title":"Distinguishing Alzheimer's Disease from Other Major Forms of Dementia","volume":"11","author":"Karantzoulis","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"B92","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.3233\/JAD-2012-129001","article-title":"Molecular Mechanisms of Amyloid Oligomers Toxicity","volume":"33","author":"Kayed","year":"2012","journal-title":"Jad"},{"key":"B93","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1021\/ML3000726","article-title":"Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators as Novel Tools for In Vivo Investigation","volume":"3","author":"Keck","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/J.CELL.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"B95","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.expneurol.2015.09.019","article-title":"Excitotoxicity in ALS: Overstimulation, or Overreaction?","volume":"275","author":"King","year":"2016","journal-title":"Exp. Neurol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/dnnd.s84956","article-title":"The Genetics of Amyotrophic Lateral Sclerosis: Current Insights","volume":"6","author":"Kirby","year":"2016","journal-title":"Dnnd"},{"key":"B97","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/MDS.25859","article-title":"Combined Fenobam and Amantadine Treatment Promotes Robust Antidyskinetic Effects in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson's Disease","volume":"29","author":"Ko","year":"2014","journal-title":"Mov. Disord."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/BRAIN\/AWT192","article-title":"Disease Duration and the Integrity of the Nigrostriatal System in Parkinson's Disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"B100","doi-asserted-by":"publisher","first-page":"14072","DOI":"10.1074\/JBC.M708551200","article-title":"Activated Nuclear Metabotropic Glutamate Receptor mGlu5 Couples to Nuclear Gq\/11 Proteins to Generate Inositol 1,4,5-Trisphosphate-Mediated Nuclear Ca2+ Release","volume":"283","author":"Kumar","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B216","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3109\/00207454.2013.841685","article-title":"Mavoglurant (AFQ056) in Combination with Increased Levodopa Dosages in Parkinson\u2019s Disease Patients","volume":"126","author":"Kumar","year":"2015","journal-title":"Int. J. Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.tips.2006.07.009","article-title":"Allosteric Agonists of 7TM Receptors: Expanding the Pharmacological Toolbox","volume":"27","author":"Langmead","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-\u03b2 Oligomers","volume":"457","author":"Laur\u00e9n","year":"2009","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/J.NEUROPHARM.2018.02.003","article-title":"A\u03b2 Pathology Downregulates Brain mGluR5 Density in a Mouse Model of Alzheimer","volume":"133","author":"Lee","year":"2018","journal-title":"Neuropharmacology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/J.NBD.2011.01.022","article-title":"AFQ056, a New mGluR5 Antagonist for Treatment of Fragile X Syndrome","volume":"42","author":"Levenga","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/FNMOL.2022.801757","article-title":"Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice","volume":"15","author":"Li","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/J.IMMUNI.2017.06.006","article-title":"Reactive Astrocytes: Production, Function, and Therapeutic Potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/GLIA.22502","article-title":"Amyloid Beta Deregulates Astroglial mGluR5-Mediated Calcium Signaling via Calcineurin and Nf-kB","volume":"61","author":"Lim","year":"2013","journal-title":"Glia"},{"key":"B108","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1124\/jpet.111.185660","article-title":"CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor","volume":"339","author":"Lindemann","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B109","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1124\/JPET.114.222463","article-title":"Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression","volume":"353","author":"Lindemann","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1021\/jm049400d","article-title":"Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 from a Series of N-(1,3-diphenyl-1H- Pyrazol-5-Yl)benzamides that Potentiate Receptor Function In Vivo","volume":"47","author":"Lindsley","year":"2004","journal-title":"J. Med. Chem."},{"key":"B111","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/NEU.2012.2589","article-title":"Activation of mGluR5 and Inhibition of NADPH Oxidase Improves Functional Recovery after Traumatic Brain Injury","volume":"30","author":"Loane","year":"2013","journal-title":"J. Neurotrauma"},{"key":"B112","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/wmts.30","article-title":"Metabotropic Glutamate Receptor-Mediated Signaling in Neuroglia","volume":"1","author":"Loane","year":"2012","journal-title":"Wiley Interdiscip. Rev. Membr. Transp. Signal"},{"key":"B113","doi-asserted-by":"publisher","first-page":"15629","DOI":"10.1074\/JBC.M806139200","article-title":"Activation of Metabotropic Glutamate Receptor 5 Modulates Microglial Reactivity and Neurotoxicity by Inhibiting NADPH Oxidase","volume":"284","author":"Loane","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s13311-014-0298-6","article-title":"Novel mGluR5 Positive Allosteric Modulator Improves Functional Recovery, Attenuates Neurodegeneration, and Alters Microglial Polarization after Experimental Traumatic Brain Injury","volume":"11","author":"Loane","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1111\/j.1460-9568.1996.tb01611.x","article-title":"Perisynaptic Location of Metabotropic Glutamate Receptors mGluR1 and mGluR5 on Dendrites and Dendritic Spines in the Rat Hippocampus","volume":"8","author":"Luj\u00e1n","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A Novel Gene Containing a Trinucleotide Repeat that Is Expanded and Unstable on Huntington's Disease Chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"B117","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/13543781003691832","article-title":"Glutamatergic Fine Tuning with ADX-10059: a Novel Therapeutic Approach for Migraine?","volume":"19","author":"Marin","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1568007023339544","article-title":"Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor","volume":"1","author":"Marino","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22115867\/S1","article-title":"The Density of Group I Mglu5 Receptors Is Reduced along the Neuronal Surface of Hippocampal Cells in a Mouse Model of Alzheimer\u2019s Disease","volume":"22","author":"Mart\u00edn-Belmonte","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/brain\/awr137","article-title":"Metabotropic Glutamate Receptor 5 Antagonist Protects Dopaminergic and Noradrenergic Neurons from Degeneration in MPTP-Treated Monkeys","volume":"134","author":"Masilamoni","year":"2011","journal-title":"Brain"},{"key":"B121","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/FNINS.2017.00647","article-title":"The Evidence for the Spread and Seeding Capacities of the Mutant Huntingtin Protein in In Vitro Systems and Their Therapeutic Implications","volume":"11","author":"Masnata","year":"2017","journal-title":"Front. Neurosci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/sj.bjp.0705159","article-title":"Positive Allosteric Modulation of the Human Metabotropic Glutamate Receptor 4 (hmGluR4) by SIB-1893 and MPEP","volume":"138","author":"Mathiesen","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S1471-4892(03)00107-3","article-title":"Allosteric Modulators of G-Protein-Coupled Receptors","volume":"3","author":"May","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's Disease: a Clinical Review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/S13195-020-0582-0","article-title":"PET Imaging of mGluR5 in Alzheimer's Disease","volume":"12","author":"Mecca","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B126","doi-asserted-by":"publisher","first-page":"118217","DOI":"10.1016\/J.NEUROIMAGE.2021.118217","article-title":"Effect of Age on Brain Metabotropic Glutamate Receptor Subtype 5 Measured with [18F]FPEB PET","volume":"238","author":"Mecca","year":"2021","journal-title":"Neuroimage"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front. Neurosci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/J.BRAINRES.2016.04.042","article-title":"ER Stress and Parkinson's Disease: Pathological Inputs that Converge into the Secretory Pathway","volume":"1648","author":"Mercado","year":"2016","journal-title":"Brain Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP Mouse Models of Parkinson's Disease: an Update","volume":"1","author":"Meredith","year":"2011","journal-title":"J. Park. Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1111\/BPH.15515","article-title":"Blocking Glutamate mGlu5 Receptors with the Negative Allosteric Modulator CTEP Improves Disease Course in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis","volume":"178","author":"Milanese","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","article-title":"Quantitative Relationships between Huntingtin Levels, Polyglutamine Length, Inclusion Body Formation, and Neuronal Death Provide Novel Insight into Huntington's Disease Molecular Pathogenesis","volume":"30","author":"Miller","year":"2010","journal-title":"J. Neurosci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s11064-014-1248-8","article-title":"mGluR5: Exploration of Orthosteric and Allosteric Ligand Binding Pockets and Their Applications to Drug Discovery","volume":"39","author":"M\u00f8lck","year":"2014","journal-title":"Neurochem. Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/J.1365-2990.2007.00910.X","article-title":"Alpha-smooth Muscle Actin (Alpha-SMA) and Nestin Expression in Reactive Astrocytes in Multiple Sclerosis Lesions: Potential Regulatory Role of Transforming Growth Factor-Beta 1 (TGF-Beta1)","volume":"34","author":"Moreels","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.neuropharm.2009.12.024","article-title":"Effect of the Metabotropic Glutamate Receptor Type 5 Antagonists MPEP and MTEP in Parkinsonian Monkeys","volume":"58","author":"Morin","year":"2010","journal-title":"Neuropharmacology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neuropharm.2012.07.036","article-title":"MPEP, an mGlu5 Receptor Antagonist, Reduces the Development of L-DOPA-Induced Motor Complications in De Novo Parkinsonian Monkeys: Biochemical Correlates","volume":"66","author":"Morin","year":"","journal-title":"Neuropharmacology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.neuropharm.2013.05.028","article-title":"Chronic Treatment with MPEP, an mGlu5 Receptor Antagonist, Normalizes Basal Ganglia Glutamate Neurotransmission in L-DOPA-Treated Parkinsonian Monkeys","volume":"73","author":"Morin","year":"","journal-title":"Neuropharmacology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/S00259-018-4179-9\/FIGURES\/6","article-title":"Metabotropic Glutamate Receptor Subtype 5 Is Altered in LPS-Induced Murine Neuroinflammation Model and in the Brains of AD and ALS Patients","volume":"46","author":"M\u00fcller Herde","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B138","doi-asserted-by":"publisher","first-page":"109648","DOI":"10.1016\/J.CELREP.2021.109648","article-title":"Agonists and Allosteric Modulators Promote Signaling from Different Metabotropic Glutamate Receptor 5 Conformations","volume":"36","author":"Nasrallah","year":"2021","journal-title":"Cell Rep."},{"key":"B139","doi-asserted-by":"publisher","first-page":"e12273","DOI":"10.1002\/trc2.12273","article-title":"A Phase 1b\/2a Multicentre Study of the Safety and Preliminary Pharmacodynamic Effects of the Selective Muscarinic M1 Receptor Agonist HTL0018318 in Patients with Mild-To-Moderate Alzheimer\u2019s Disease","volume":"8","author":"Nathan","year":"2022","journal-title":"Alzheimer\u2019s Dementia"},{"key":"B140","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1007\/S10072-021-05319-7","article-title":"Mavoglurant (AFQ056) for the Treatment of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease: a Meta-Analysis","volume":"42","author":"Negida","year":"2021","journal-title":"Neurol. Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/J.1750-3639.2007.00101.X","article-title":"Glutamate Receptor Expression in Multiple Sclerosis Lesions","volume":"18","author":"Newcombe","year":"2008","journal-title":"Brain Pathol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The Role of Autophagy in Neurodegenerative Disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1124\/mol.64.3.731","article-title":"A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5","volume":"64","author":"O'Brien","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1124\/jpet.103.061747","article-title":"A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain","volume":"309","author":"O'Brien","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/sj.bjp.0703715","article-title":"Selective mGluR5 Antagonists MPEP and SIB-1893 Decrease NMDA or Glutamate-Mediated Neuronal Toxicity through Actions that Reflect NMDA Receptor Antagonism","volume":"131","author":"O'Leary","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuropharm.2005.04.002","article-title":"MTEP, a New Selective Antagonist of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5), Produces Antiparkinsonian-like Effects in Rats","volume":"49","author":"Ossowska","year":"2005","journal-title":"Neuropharmacology"},{"key":"B147","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/J.PHARMTHERA.2007.04.007","article-title":"Metabotropic Glutamate Receptor Ligands as Possible Anxiolytic and Antidepressant Drugs","volume":"115","author":"Palucha","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"B148","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/J.NEUROPHARM.2012.12.003","article-title":"Mechanism Based Neurotoxicity of mGlu5 Positive Allosteric Modulators-Ddevelopment Challenges for a Promising Novel Antipsychotic Target","volume":"82","author":"Parmentier-Batteur","year":"2014","journal-title":"Neuropharmacology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00004714-198204000-00010","article-title":"Treatment of Anxiety Using Fenobam (A Nonbenzodiazepine) in a Double-Blind Standard (Diazepam) Placebo-Controlled Study","volume":"2","author":"Pecknold","year":"1982","journal-title":"J. Clin. Psychopharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/PHYSREV.00041.2013","article-title":"Astrocyte Reactivity and Reactive Astrogliosis: Costs and Benefits","volume":"94","author":"Pekny","year":"2014","journal-title":"Physiol. Rev."},{"key":"B151","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/J.NEULET.2011.10.007","article-title":"Positive Allosteric Modulation of Metabotropic Glutamate Receptor 5 Down-Regulates Fibrinogen-Activated Microglia Providing Neuronal Protection","volume":"505","author":"Piers","year":"2011","journal-title":"Neurosci. Lett."},{"key":"B152","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fphar.2016.00295","article-title":"Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System","volume":"7","author":"Pittaluga","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson Disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B154","doi-asserted-by":"publisher","first-page":"a009308","DOI":"10.1101\/cshperspect.a009308","article-title":"Modeling Parkinson's Disease in Primates: The MPTP Model","volume":"2","author":"Porras","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1124\/jpet.105.089839","article-title":"Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity","volume":"315","author":"Porter","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B156","doi-asserted-by":"publisher","first-page":"e14020","DOI":"10.1371\/JOURNAL.PONE.0014020","article-title":"Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy-Iimplications for Excitotoxicity","volume":"5","author":"Price","year":"2010","journal-title":"PloS one"},{"key":"B157","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1523\/JNEUROSCI.3451-13.2014","article-title":"Intracellular mGluR5 Can Mediate Synaptic Plasticity in the hippocampus","volume":"34","author":"Purgert","year":"2014","journal-title":"J. Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/CQIU","article-title":"Epidemiology of Alzheimer's Disease: Occurrence, Determinants, and Strategies toward Intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/SCIENCE.AAG2590","article-title":"How Neuroinflammation Contributes to Neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"B160","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/MDS.26174","article-title":"A Randomized, Placebo-Controlled Trial of AFQ056 for the Treatment of Chorea in Huntington's Disease","volume":"30","author":"Reilmann","year":"2015","journal-title":"Mov. Disord."},{"key":"B161","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious Effects of Amyloid Beta Oligomers Acting as an Extracellular Scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1517\/14728222.2014.948419","article-title":"Metabotropic Glutamate Receptor 5 as a Potential Therapeutic Target in Huntington's Disease","volume":"18","author":"Ribeiro","year":"","journal-title":"Expert Opin. Ther. Targets"},{"key":"B163","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1523\/JNEUROSCI.4974-09.2010","article-title":"Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease","volume":"30","author":"Ribeiro","year":"2010","journal-title":"J. Neurosci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/hmg\/ddt598","article-title":"Metabotropic Glutamate Receptor 5 Knockout Promotes Motor and Biochemical Alterations in a Mouse Model of Huntington's Disease","volume":"23","author":"Ribeiro","year":"","journal-title":"Hum. Mol. Genet."},{"key":"B165","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.2174\/138161209789649303","article-title":"Turning REST\/NRSF Dysfunction in Huntington's Disease into a Pharmaceutical Target","volume":"15","author":"Rigamonti","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"B166","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature08144","article-title":"The Structure and Function of G-Protein-Coupled Receptors","volume":"459","author":"Rosenbaum","year":"2009","journal-title":"Nature"},{"key":"B167","doi-asserted-by":"publisher","first-page":"111691","DOI":"10.1038\/cdd.2008.99","article-title":"Focal Degeneration of Astrocytes in Amyotrophic Lateral Sclerosis","volume":"15","author":"Rossi","year":"20082008","journal-title":"Cell Death Differ."},{"key":"B168","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/S12325-016-0468-5","article-title":"Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-Of-Concept, Randomized, Placebo-Controlled, Phase 2 Study","volume":"34","author":"Rutrick","year":"2017","journal-title":"Adv. Ther."},{"key":"B169","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","article-title":"A mGluR5 Antagonist under Clinical Development Improves L-DOPA-Induced Dyskinesia in Parkinsonian Rats and Monkeys","volume":"39","author":"Rylander","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B170","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/FNINS.2017.00451\/BIBTEX","article-title":"Axonal Degeneration during Aging and its Functional Role in Neurodegenerative Disorders","volume":"11","author":"Salvadores","year":"2017","journal-title":"Front. Neurosci."},{"key":"B171","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A Comprehensive Map of Molecular Drug Targets","volume":"16","author":"Santos","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"B217","doi-asserted-by":"publisher","first-page":"107402","DOI":"10.1016\/J.PHARMTHERA.2019.107402","article-title":"Novel Pharmacological Targets in Drug Development for the Treatment of Anxiety and Anxiety-Related Disorders","volume":"204","author":"Sartori","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"B172","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/BS.APHA.2019.12.003","article-title":"M1 Muscarinic Acetylcholine Receptors: A Therapeutic Strategy for Symptomatic and Disease-Modifying Effects in Alzheimer's Disease?","volume":"88","author":"Scarpa","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.brainres.2004.06.005","article-title":"The Metabotropic Glutamate Receptor 5 Antagonist MPEP and the mGluR2 Agonist LY379268 Modify Disease Progression in a Transgenic Mouse Model of Huntington's Disease","volume":"1019","author":"Schiefer","year":"2004","journal-title":"Brain Res."},{"key":"B174","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/FNCEL.2018.00261","article-title":"Important Shapeshifter: Mechanisms Allowing Astrocytes to Respond to the Changing Nervous System during Development, Injury and Disease","volume":"12","author":"Schiweck","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"B175","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic Toxin-Induced Animal Models of Parkinson's Disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"key":"B176","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-9-52\/FIGURES\/5_547","article-title":"Involvement of Metabotropic Glutamate Receptor 5, AKT\/PI3K Signaling and NF-\u03baB Pathway in Methamphetamine-Mediated Increase in IL-6 and IL-8 Expression in Astrocytes","volume":"9","author":"Shah","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B177","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/neur.1995.0026","article-title":"CSF and Plasma Amino Acid Levels in Motor Neuron Disease: Elevation of CSF Glutamate in a Subset of Patients","volume":"4","author":"Shaw","year":"1995","journal-title":"Neurodegeneration"},{"key":"B178","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0304-3940(93)90227-C","article-title":"Immunohistochemical Localization of a Metabotropic Glutamate Receptor, mGluR5, in the Rat Brain","volume":"163","author":"Shigemoto","year":"1993","journal-title":"Neurosci. Lett."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/GLIA.22548","article-title":"\u03b2-Amyloid and ATP-Induced Diffusional Trapping of Astrocyte and Neuronal Metabotropic Glutamate Type-5 Receptors","volume":"61","author":"Shrivastava","year":"2013","journal-title":"Glia"},{"key":"B218","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1093\/bioinformatics\/btx441","article-title":"Reactome enhanced pathway visualization","volume":"33","author":"Sidiropoulos","year":"2017","journal-title":"Bioinform."},{"key":"B180","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0304-3940(99)00145-7","article-title":"Group I and II Metabotropic Glutamate Receptor Expression in Cultured Rat Spinal Cord Astrocytes","volume":"263","author":"Silva","year":"1999","journal-title":"Neurosci. Lett."},{"key":"B181","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-Hydroxydopamine Model of Parkinson's Disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1358\/dnp.2005.18.6.927927","article-title":"The Role of Metabotropic Glutamate Receptor 5 in Learning and Memory Processes","volume":"18","author":"Simonyi","year":"2005","journal-title":"Drug News Perspect."},{"key":"B183","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/FNMOL.2018.00414\/BIBTEX","article-title":"Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?","volume":"11","author":"Spampinato","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B184","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0014-2999(00)00697-X","article-title":"Effects of the Prototypical mGlu(5) Receptor Antagonist 2-Methyl-6-(phenylethynyl)-Pyridine on Rotarod, Locomotor Activity and Rotational Responses in Unilateral 6-OHDA-Lesioned Rats","volume":"406","author":"Spooren","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/mol.117.111062","article-title":"G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?","volume":"93","author":"Sriram","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/PNAS.100110097","article-title":"The Huntington's Disease Protein Interacts with P53 and CREB-Binding Protein and Represses Transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/mds.25561","article-title":"AFQ056 in Parkinson Patients with Levodopa-Induced Dyskinesia: 13-week, Randomized, Dose-Finding Study","volume":"28","author":"Stocchi","year":"2013","journal-title":"Mov. Disord."},{"key":"B188","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.celrep.2017.02.075","article-title":"\u03b2-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X","volume":"18","author":"Stoppel","year":"2017","journal-title":"Cell Rep."},{"key":"B189","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and Huntingtin-Associated Protein 1 Influence Neuronal Calcium Signaling Mediated by Inositol-(1,4,5) Triphosphate Receptor Type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"B190","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/CNE.903540207","article-title":"Differential Expression of mGluR5 Metabotropic Glutamate Receptor mRNA by Rat Striatal Neurons","volume":"354","author":"Testa","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","article-title":"Levodopa-induced Dyskinesia in Parkinson's Disease: Clinical Features, Pathogenesis, Prevention and Treatment","volume":"83","author":"Thanvi","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"B192","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/J.1474-9726.2007.00295.X","article-title":"Expansion of the Calcium Hypothesis of Brain Aging and Alzheimer's Disease: Minding the Store","volume":"6","author":"Thibault","year":"2007","journal-title":"Aging cell"},{"key":"B193","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/mds.26659","article-title":"A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease","volume":"31","author":"Tison","year":"2016","journal-title":"Mov. Disord."},{"key":"B195","doi-asserted-by":"publisher","first-page":"e01632","DOI":"10.1002\/BRB3.1632","article-title":"Reduced Uptake of [11C]-Abp688, a PET Tracer for Metabolic Glutamate Receptor 5 in hippocampus and Amygdala in Alzheimer's Dementia","volume":"10","author":"Treyer","year":"2020","journal-title":"Brain Behav."},{"key":"B196","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1042\/CS20180374","article-title":"Biased Agonism and Allosteric Modulation of Metabotropic Glutamate Receptor 5","volume":"132","author":"Trinh","year":"2018","journal-title":"Clin. Sci. (Lond)"},{"key":"B197","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.clinthera.2016.10.007","article-title":"Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056)","volume":"38","author":"Ufer","year":"2016","journal-title":"Clin. Ther."},{"key":"B198","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer A\u03b2 Oligomer Bound to Cellular Prion Protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"B199","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0168-0102(97)01175-9","article-title":"mGluR5 Metabotropic Glutamate Receptor Distribution in Rat and Human Spinal Cord: a Developmental Study","volume":"28","author":"Valerio","year":"1997","journal-title":"Neurosci. Res."},{"key":"B200","first-page":"358","article-title":"Pharmacological Characterization of the Human Ionotropic Glutamate Receptor Subtype GluR3 Stably Expressed in Mammalian Cells","volume":"285","author":"Varney","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B201","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/GLIA.23279","article-title":"Constitutive Downregulation Protein Kinase C Epsilon in hSOD1G93A Astrocytes Influences mGluR5 Signaling and the Regulation of Glutamate Uptake","volume":"66","author":"Vergouts","year":"2018","journal-title":"Glia"},{"key":"B202","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/J.1471-4159.2005.03577.X","article-title":"Loss of Metabotropic Glutamate Receptor-Mediated Regulation of Glutamate Transport in Chemically Activated Astrocytes in a Rat Model of Amyotrophic Lateral Sclerosis","volume":"96","author":"Vermeiren","year":"2006","journal-title":"J. Neurochem."},{"key":"B203","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/J.1471-4159.2005.03216.X","article-title":"Acute Up-Regulation of Glutamate Uptake Mediated by mGluR5a in Reactive Astrocytes","volume":"94","author":"Vermeiren","year":"2005","journal-title":"J. Neurochem."},{"key":"B204","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/J.1476-5381.2008.00078.X","article-title":"Molecular Basis for Amino Acid Sensing by Family C G-Protein-Coupled Receptors","volume":"156","author":"Wellendorph","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2967\/JNUMED.112.107995","article-title":"18F-FPEB, a PET Radiopharmaceutical for Quantifying Metabotropic Glutamate 5 Receptors: A First-In-Human Study of Radiochemical Safety, Biokinetics, and Radiation Dosimetry","volume":"54","author":"Wong","year":"2013","journal-title":"J. Nucl. Med."},{"key":"B206","doi-asserted-by":"publisher","first-page":"e17947","DOI":"10.1371\/journal.pone.0017947","article-title":"Disease-related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC\/TOFMS","volume":"6","author":"Wuolikainen","year":"2011","journal-title":"PLoS ONE"},{"key":"B207","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00311389","article-title":"Vimentin Immunoreactivity in Normal and Pathological Human Brain Tissue","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/J.NEULET.2017.06.029","article-title":"Activated mGluR5 Protects BV2 Cells against OGD\/R Induced Cytotoxicity by Modulating BDNF-TrkB Pathway","volume":"654","author":"Ye","year":"2017","journal-title":"Neurosci. Lett."},{"key":"B209","doi-asserted-by":"publisher","first-page":"fcaa058","DOI":"10.1093\/BRAINCOMMS\/FCAA058","article-title":"M1 Muscarinic Acetylcholine Receptor Dysfunction in Moderate Alzheimer's Disease Pathology","volume":"2","author":"Yi","year":"2020","journal-title":"Brain Commun."},{"key":"B210","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and Future Treatments for Alzheimer's Disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B211","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/NPP.2017.177","article-title":"Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results","volume":"43","author":"Youssef","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B212","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","article-title":"Genomic Analysis of Reactive Astrogliosis","volume":"32","author":"Zamanian","year":"2012","journal-title":"J. Neurosci."},{"key":"B213","doi-asserted-by":"publisher","first-page":"e06734","DOI":"10.7554\/eLife.06734.001","article-title":"G-protein-coupled Receptors Regulate Autophagy by ZBTB16-Mediated Ubiquitination and Proteasomal Degradation of Atg14L","volume":"4","author":"Zhang","year":"2015","journal-title":"Elife"},{"key":"B214","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/S12974-021-02079-1","article-title":"Metabotropic Glutamate Receptor 5 Inhibits \u03b1-synuclein-induced Microglia Inflammation to Protect from Neurotoxicity in Parkinson's Disease","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflammation"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.893422\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T01:47:05Z","timestamp":1652233625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.893422\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":215,"alternative-id":["10.3389\/fphar.2022.893422"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.893422","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"893422"}}